US OptionsDetailed Quotes

BTAI240517C500

Watchlist

2.90
0.000.00%

15min DelayClose May 17 15:35 ET

0.00High0.00Low

BioXcel Therapeutics Stock Discussion

JESSE JAMES8832

May 9 19:24

news

$BioXcel Therapeutics(BTAI.US)$BioXcel Therapeutics Q1 2024 GAAP EPS $(0.87) Beats $(1.04) Estimate, Sales $582.000K Beat $464.000K Estimate

Jaguar8

Apr 24 22:31

$BioXcel Therapeutics(BTAI.US)$
NEWS
BioXcel Therapeutics Announces Late-Breaking Abstract on Preliminary Findings from Phase 2 Investigator-Sponsored Trial of BXCL701 and KEYTRUDA® in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) Selected for Presentation at 2024 ASCO Annual Meeting
The late-breaking abstract on preliminary findings from the Phase 2 trial of BXCL701 and KEYTRUDA® in metastatic pancreatic ductal adenocarcinoma has been selected for presentation at the 2024 ASCO Annual Meeti...

Trytosaveabit

Apr 10 19:08

Hmm?

$BioXcel Therapeutics(BTAI.US)$ BioXcel Therapeutics Announced Details Regarding The Planned Design Of Its Upcoming TRANQUILITY In-care Phase 3 Trial Of BXCL501 For Agitation Associated With Alzheimer's Dementia

Trytosaveabit

Mar 15 19:13

$BioXcel Therapeutics(BTAI.US)$ BioXcel Therapeutics Announces European Patent Office's Grant of Patent for Method of Treating Agitation in Dementia Using Sublingual Dexmedetomidine
13 MINUTES AGO, 7:00 AM EDT
VIA GLOBENEWSWIRE